|
FDA
|
8
|
Resverlogix Corp.
|
Sep 30, 2019 01:54PM
|
|
Good post SanFran
|
1
|
Zenith Epigenetics
|
May 28, 2019 01:25PM
|
|
New Patent
|
2
|
Resverlogix Corp.
|
Nov 16, 2019 07:31PM
|
|
NR
|
3
|
Resverlogix Corp.
|
Jan 23, 2017 11:01AM
|
|
people whining about the people whining about the whining
|
3
|
Resverlogix Corp.
|
Dec 23, 2020 06:32PM
|
|
PNH
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 08:27PM
|
|
Presentation a liitle over an hour away
|
3
|
Resverlogix Corp.
|
Jun 19, 2017 06:12PM
|
|
Re: ... has anybody received
|
1
|
Resverlogix Corp.
|
Nov 28, 2016 03:03PM
|
|
Re: ... unfinished business
|
6
|
Zenith Epigenetics
|
Oct 31, 2018 03:26PM
|
|
Re: ...clinical steering committee are in discussions
|
2
|
Resverlogix Corp.
|
Sep 29, 2017 10:33PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
2
|
Resverlogix Corp.
|
Feb 13, 2020 04:58PM
|
|
Re: 3 cheers for Don and the RVX team
|
6
|
Resverlogix Corp.
|
Feb 03, 2020 08:37PM
|
|
Re: 3 cheers for Don and the RVX team
|
6
|
Resverlogix Corp.
|
Feb 03, 2020 09:03PM
|
|
Re: 3 cheers for Don and the RVX team
|
6
|
Resverlogix Corp.
|
Feb 03, 2020 09:13PM
|
|
Re: A couple of things....
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 08:41PM
|
|
Re: A few thoughts on Soliris(Eculizumab) vs. RVX-208 for Compliment-related disease
|
1
|
Resverlogix Corp.
|
Sep 25, 2015 10:31AM
|
|
Re: A Homecoming of Sorts...book value question
|
3
|
Resverlogix Corp.
|
Sep 21, 2015 11:18AM
|
|
Re: A Homecoming of Sorts...book value question
|
3
|
Resverlogix Corp.
|
Sep 21, 2015 11:44AM
|
|
Re: A Homecoming of Sorts...book value question
|
|
Resverlogix Corp.
|
Sep 21, 2015 02:59PM
|
|
Re: A Homecoming of Sorts...book value question
|
|
Resverlogix Corp.
|
Sep 21, 2015 05:19PM
|
